Free tool
FAERS Monitor: Stromectol
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050742 or its brand name (Stromectol, Ivermectin). Reports on generic versions are filed under their own applications.
Reports
4,851
Serious
3,461
71% of reports
Hospitalization
2,161
Death reported
563
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- headache611
- asthenia582
- pyrexia474
- off label use463
- drug ineffective450
- product use in unapproved indication415
- diarrhoea267
- ocular hyperaemia248
- coma247
- conjunctival haemorrhage237
- back pain224
- vertigo215
- pruritus207
- arthralgia195
- vomiting191
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 95 |
| 2005 | 63 |
| 2006 | 360 |
| 2007 | 96 |
| 2008 | 186 |
| 2009 | 84 |
| 2010 | 139 |
| 2011 | 53 |
| 2012 | 72 |
| 2013 | 92 |
| 2014 | 107 |
| 2015 | 110 |
| 2016 | 89 |
| 2017 | 110 |
| 2018 | 195 |
| 2019 | 190 |
| 2020 | 216 |
| 2021 | 467 |
| 2022 | 426 |
| 2023 | 350 |
| 2024 | 361 |
| 2025 | 555 |
| 2026 | 435 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,308 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| conjunctival haemorrhageSignal | 237 | 286.7 | 252.1 | 63,036 |
| ocular hyperaemiaSignal | 248 | 22.8 | 20.2 | 5,125 |
| comaSignal | 247 | 22.6 | 20.0 | 5,063 |
| vertigoSignal | 215 | 15.3 | 13.5 | 2,867 |
| product use in unapproved indicationSignal | 415 | 7.3 | 6.6 | 2,261 |
| astheniaSignal | 582 | 6.7 | 6.2 | 2,875 |
| pyrexiaSignal | 474 | 5.9 | 5.5 | 1,975 |
| headacheSignal | 611 | 4.2 | 3.9 | 1,548 |
| back painSignal | 224 | 4.2 | 3.7 | 545 |
| pruritusSignal | 207 | 2.3 | 2.0 | 160 |
| off label useSignal | 463 | 2.3 | 2.1 | 351 |
| arthralgiaSignal | 195 | 2.0 | 1.8 | 103 |
| diarrhoea | 267 | 1.8 | 1.6 | 96 |
| vomiting | 191 | 1.8 | 1.5 | 64 |
| drug ineffective | 450 | 1.5 | 1.4 | 74 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.